Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitri Mouradov

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Cell Reports. Medicine|December 20, 2023
Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancerTao Tan, Dmitri Mouradov, Margaret Lee, et al.
BMJ Oncology|October 29, 2025
Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancersPavitha Parathan, Kelly Tran, Liam Neil, et al.
Proteomics|April 30, 2015
FunRich: An open access standalone functional enrichment and interaction network analysis toolMohashin Pathan, Shivakumar Keerthikumar, Ching-Seng Ang, et al.
Cell Death & Disease|March 1, 2024
BCL-X<sub>L</sub> inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF<sup>V600E</sup> colorectal cancerLaura J Jenkins, Ian Y Luk, Fiona Chionh, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcomaAndrew Farrell, Genevieve Dall, Cassandra J Vandenberg, et al.
Oncogene|March 26, 2021
CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylationAnderly C Chüeh, Gahana Advani, Momeneh Foroutan, et al.
The American Journal of Gastroenterology|September 18, 2013
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutationsDmitri Mouradov, Enric Domingo, Peter Gibbs, et al.
Iscience|November 16, 2019
Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug TargetsDavid K Lau, Dmitri Mouradov, Wiphawan Wasenang, et al.
Gut|December 24, 2025
Comparison between germline and somatic loss-of-function <i>RNF43</i> mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesisClaire Palles, Luke Freeman-Mills, Edward Arbe-Barnes, et al.
British Journal of Cancer|August 26, 2015
Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancerRobert N Jorissen, Michael Christie, Dmitri Mouradov, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cell Reports. Medicine|December 20, 2023
Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancerTao Tan, Dmitri Mouradov, Margaret Lee, et al.
BMJ Oncology|October 29, 2025
Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancersPavitha Parathan, Kelly Tran, Liam Neil, et al.
Proteomics|April 30, 2015
FunRich: An open access standalone functional enrichment and interaction network analysis toolMohashin Pathan, Shivakumar Keerthikumar, Ching-Seng Ang, et al.
Cell Death & Disease|March 1, 2024
BCL-X<sub>L</sub> inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF<sup>V600E</sup> colorectal cancerLaura J Jenkins, Ian Y Luk, Fiona Chionh, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcomaAndrew Farrell, Genevieve Dall, Cassandra J Vandenberg, et al.
Oncogene|March 26, 2021
CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylationAnderly C Chüeh, Gahana Advani, Momeneh Foroutan, et al.
The American Journal of Gastroenterology|September 18, 2013
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutationsDmitri Mouradov, Enric Domingo, Peter Gibbs, et al.
Iscience|November 16, 2019
Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug TargetsDavid K Lau, Dmitri Mouradov, Wiphawan Wasenang, et al.
Gut|December 24, 2025
Comparison between germline and somatic loss-of-function <i>RNF43</i> mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesisClaire Palles, Luke Freeman-Mills, Edward Arbe-Barnes, et al.
British Journal of Cancer|August 26, 2015
Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancerRobert N Jorissen, Michael Christie, Dmitri Mouradov, et al.
Pageof 5